Catalyst Biosciences Inc (CBIO.OQ)
CBIO.OQ on NASDAQ Stock Exchange Capital Market
7.51USD
24 Jun 2019
7.51USD
24 Jun 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
$7.51
$7.51
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
40,823
40,823
52-wk High
$14.35
$14.35
52-wk Low
$6.20
$6.20
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 0.00 | -1.261 |
| FY 2018 | Dec '18 | 0.00 | -0.907 |
| Sep '18 | 0.00 | -0.644 | |
| Jun '18 | 0.00 | -0.543 | |
| Mar '18 | 0.01 | -0.561 | |
| FY 2017 | Dec '17 | 0.32 | -1.261 |
| Sep '17 | 0.32 | -1.344 | |
| Jun '17 | 0.11 | -2.534 | |
| Mar '17 | 0.27 | -4.567 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-19 | 3 | 0.30 | 0.90 | 0.00 | 0.00 |
| Year Ending Dec-19 | 3 | 0.30 | 0.90 | 0.00 | 0.00 |
| Year Ending Dec-20 | 2 | 0.73 | 1.45 | 0.00 | 19.03 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 3 | -1.11 | -1.02 | -1.20 | -0.80 |
| Quarter Ending Sep-19 | 3 | -1.04 | -0.93 | -1.19 | -0.72 |
| Year Ending Dec-19 | 3 | -4.48 | -4.01 | -4.88 | -3.41 |
| Year Ending Dec-20 | 2 | -3.55 | -3.47 | -3.62 | -2.93 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 29.30 | 32.55 | |
| P/E High - Last 5 Yrs. | -- | 43.17 | 48.11 | |
| P/E Low - Last 5 Yrs. | -- | 22.71 | 23.41 | |
| Beta | 1.35 | 0.86 | 0.87 | |
| Price to Sales (TTM) | 43.72 | 6.60 | 8.44 | |
| Price to Book (MRQ) | 0.81 | 5.12 | 5.27 | |
| Price to Tangible Book (MRQ) | 0.81 | 5.84 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 23.07 | 24.12 | |
| % Owned Institutions | 33.39 | 0.87 | 1.65 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.43 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 1.45 | 1.37 | |
| Dividend 5 Year Growth Rate | -- | 4.00 | 4.71 | |
| Payout Ratio(TTM) | -- | 42.19 | 39.59 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 1.83 | 5.43 | 13.45 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 28.90 | 6.61 | 8.04 | |
| Sales - 5 Yr. Growth Rate | -66.71 | 10.48 | 10.84 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 59.98 | 46.17 | 48.19 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 43.85 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 9.90 | 10.46 | |
| Capital Spending - 5 Yr. Growth Rate | -20.03 | 15.26 | 14.68 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.07 | 2.18 |
| Current Ratio (MRQ) | 4.23 | 2.87 | 2.98 |
| LT Debt to Equity (MRQ) | 0.00 | 8.87 | 11.35 |
| Total Debt to Equity (MRQ) | 19.01 | 12.87 | 16.04 |
| Interest Coverage (TTM) | -32.83 | 32.47 | 28.45 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 52.06 | 52.36 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.67 | 50.39 | |
| EBITD Margin (TTM) | -3,698.75 | -- | -- | |
| EBITD - 5 Yr. Avg | -82.54 | 17.26 | 12.41 | |
| Operating Margin (TTM) | -3,745.02 | 13.47 | 5.62 | |
| Operating Margin - 5 Yr. Avg. | -96.22 | 13.69 | 8.00 | |
| Pre-Tax Margin (TTM) | -3,298.22 | 11.82 | 4.64 | |
| Pre-Tax Margin - 5 Yr. Avg. | -88.84 | 14.09 | 8.28 | |
| Net Profit Margin (TTM) | -3,298.22 | 8.73 | 1.37 | |
| Net Profit Margin - 5 Yr. Avg. | -88.67 | 10.58 | 4.69 | |
| Effective Tax Rate (TTM) | -- | 22.12 | 22.13 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.26 | 22.58 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 56,200 | 928,391,941 | 819,624,671 | |
| Net Income/Employee (TTM) | -1,853,600 | 105,138,175 | 92,776,869 | |
| Receivable Turnover (TTM) | 1.88 | 5.84 | 5.82 | |
| Inventory Turnover (TTM) | -- | 2.57 | 3.42 | |
| Asset Turnover (TTM) | 0.01 | 0.93 | 0.90 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -38.28 | 10.98 | 10.65 | |
| Return on Assets - 5 Yr. Avg. | -9.94 | 12.41 | 11.77 | |
| Return on Investment (TTM) | -68.74 | 14.23 | 13.82 | |
| Return on Investment - 5 Yr. Avg. | -12.47 | 16.18 | 15.32 | |
| Return on Equity (TTM) | -83.55 | 15.46 | 15.24 | |
| Return on Equity - 5 Yr. Avg. | -16.87 | 17.07 | 16.41 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -77.20 | -8.63 | -66.71 |
| EPS (TTM) % | 56.50 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Catalyst Biosciences Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 61.02 | 55.47 | 98 | 30 |
| 13 Week | 23.64 | 17.62 | 88 | 42 |
| 26 Week | 4.59 | -3.36 | 62 | 43 |
| 52 Week | -67.80 | -72.70 | 5 | 11 |
| YTD | -41.55 | -48.67 | 10 | 39 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 82.84% |
| # of Holders: | 96 |
| Total Shares Held: | 9,924,632 |
| 3 Mo. Net Change: | 1,334,117 |
| # New Positions: | 10 |
| # Closed Positions: | 10 |
| # Increased Positions: | 36 |
| # Reduced Positions: | 42 |
| # Net Buyers: | -6 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.